Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with B-cell acute lymphoblastic leukemia (a type of blood cancer)
- People who are 16 years of age or older
- People for whom medical records are available showing the status of their disease both before and after a stem cell transplant
Who may not be able to join:
- People who received a specific cancer medication called blinatumomab for more than 14 days
- People whose leukemia made up 10% or more of their cells before treatment began
- People who had serious problems with major organs before treatment, such as a heart attack, chronic heart failure, severe liver problems, kidney problems, or digestive system problems
- People whose leukemia had spread to the brain or spinal cord
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.